Baylis Medical announced the first clinical use of the VersaCross® Large Access Solution.
TORONTO, July 29, 2021 /PRNewswire/ - Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution. The new solution includes the world’s first 3-in-1 RF wire paired with a seamless shapeable dilator designed to optimize tissue dilation for large sheath procedures, including left atrial appendage closure, transvenous mitral valve repair, radiofrequency ablation, and a number of emerging left sided therapies.
Dr. Devi Nair, Electrophysiologist at White River Medical Center, Batesville, Arkansas, USA, performed the first-in-human case with use of the VersaCross® Large Access Solution during an Arctic Front Advance™ cryoballoon ablation procedure.
“The transition free dilator used in conjunction with the sturdy 0.035" RF wire helps enable seamless delivery of the cryo ablation sheath and system. This new solution helps address the ongoing need to simplify transseptal workflows involving large access sheaths, which have emerged as a standard part of my practice,” said Dr. Nair.
The VersaCross Large Access Solution features a seamless dilator which optimizes tissue dilation for large sheath access, at both the groin and through the atrial septum. After dilating the transseptal puncture, the septum is primed to enable a large bore therapeutic sheath to cross and reach the pulmonary veins for cardiac ablation.
The solution also includes a 3-in-1 wire with Baylis’ proprietary RF puncture technology. The electrode-tipped wire acts as a starter wire, a transseptal puncture device, and a 0.035" exchange wire in the left atrium, without the need for device exchanges.
“We are always looking to optimize access of left heart therapies, including addressing emerging patient and physician needs,” said Michael Wong, Vice President of Global Marketing at Baylis Medical. “The VersaCross Large Access Solution builds on the success of our exchangeless RF wire platform, with a dedicated solution for large sheath therapy cases.”
The addition of the VersaCross Large Access Solution will enable the delivery of a broader range of therapy devices for electrophysiology and interventional cardiology procedures.
Join our priority list to stay up to date on the latest information, here.
About Baylis Medical
Baylis Medical is a leader in the development and commercialization of innovative cardiology devices that enable life-saving therapies. Headquartered in Canada, and with offices world-wide, our clinical solutions have been Improving the Lives of People Around the World for over 30 years. For more information, visit baylismedical.com and connect with us on Twitter, LinkedIn and Instagram.
PRM-00777 EN J-1,2 V-1 © Baylis Medical Company Inc., 2021. Baylis Medical Company Inc. reserves the right to change specifications or to incorporate design changes without notice and without incurring any obligation relating to equipment previously manufactured or delivered. VersaCross, Baylis Medical, and the Baylis Medical logo are trademarks and/or registered trademarks of Baylis Medical Company Inc. in the USA and/or other countries. Other trademarks are property of their respective owners. Patents pending and/or issued. CAUTION: Federal Law (USA) restricts the use of these devices to or by the order of a physician. Before use, consult product labels and Instructions for Use for Indications for Use, Contraindications, Warnings, Precautions, Adverse Events and Directions for Use.
Products shown may not be approved in all jurisdictions.
View original content:https://www.prnewswire.com/news-releases/baylis-medical-announces-first-clinical-use-of-the-versacross-large-access-solution-to-deliver-large-bore-therapy-solutions-301343745.html
SOURCE Baylis Medical Company Inc.
